[go: up one dir, main page]

SE0200876L - Nässpray mot öroninflammationer - Google Patents

Nässpray mot öroninflammationer

Info

Publication number
SE0200876L
SE0200876L SE0200876A SE0200876A SE0200876L SE 0200876 L SE0200876 L SE 0200876L SE 0200876 A SE0200876 A SE 0200876A SE 0200876 A SE0200876 A SE 0200876A SE 0200876 L SE0200876 L SE 0200876L
Authority
SE
Sweden
Prior art keywords
nasal spray
ear inflammation
spray against
against ear
medicament
Prior art date
Application number
SE0200876A
Other languages
English (en)
Other versions
SE0200876D0 (sv
Inventor
Krister Tano
Original Assignee
Krister Tano
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Krister Tano filed Critical Krister Tano
Priority to SE0200876A priority Critical patent/SE0200876L/sv
Publication of SE0200876D0 publication Critical patent/SE0200876D0/sv
Priority to DE60310212T priority patent/DE60310212T2/de
Priority to ES03745048T priority patent/ES2277641T3/es
Priority to AU2003215987A priority patent/AU2003215987A1/en
Priority to EP03745048A priority patent/EP1490096B1/en
Priority to AT03745048T priority patent/ATE347370T1/de
Priority to US10/508,590 priority patent/US20050238635A1/en
Priority to PCT/SE2003/000384 priority patent/WO2003080109A1/en
Publication of SE0200876L publication Critical patent/SE0200876L/sv

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00Medicinal preparations containing inorganic active ingredients
    • A61K33/40Peroxides
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides
    • A61K38/16Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/43Enzymes; Proenzymes; Derivatives thereof
    • A61K38/44Oxidoreductases (1)
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides
    • A61K38/16Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/43Enzymes; Proenzymes; Derivatives thereof
    • A61K38/44Oxidoreductases (1)
    • A61K38/443Oxidoreductases (1) acting on CH-OH groups as donors, e.g. glucose oxidase, lactate dehydrogenase (1.1)
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides
    • A61K38/16Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/43Enzymes; Proenzymes; Derivatives thereof
    • A61K38/46Hydrolases (3)
    • A61K38/47Hydrolases (3) acting on glycosyl compounds (3.2), e.g. cellulases, lactases
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/0012Galenical forms characterised by the site of application
    • A61K9/0043Nose
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04Antibacterial agents
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12YENZYMES
    • C12Y101/00Oxidoreductases acting on the CH-OH group of donors (1.1)
    • C12Y101/03Oxidoreductases acting on the CH-OH group of donors (1.1) with a oxygen as acceptor (1.1.3)
    • C12Y101/03004Glucose oxidase (1.1.3.4)
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12YENZYMES
    • C12Y111/00Oxidoreductases acting on a peroxide as acceptor (1.11)
    • C12Y111/01Peroxidases (1.11.1)
    • C12Y111/01001NADH peroxidase (1.11.1.1)
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12YENZYMES
    • C12Y111/00Oxidoreductases acting on a peroxide as acceptor (1.11)
    • C12Y111/01Peroxidases (1.11.1)
    • C12Y111/01007Peroxidase (1.11.1.7), i.e. horseradish-peroxidase
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12YENZYMES
    • C12Y302/00Hydrolases acting on glycosyl compounds, i.e. glycosylases (3.2)
    • C12Y302/01Glycosidases, i.e. enzymes hydrolysing O- and S-glycosyl compounds (3.2.1)

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Zoology (AREA)
  • Biochemistry (AREA)
  • General Engineering & Computer Science (AREA)
  • Genetics & Genomics (AREA)
  • Wood Science & Technology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Immunology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Inorganic Chemistry (AREA)
  • Otolaryngology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Oncology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Communicable Diseases (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Enzymes And Modification Thereof (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
SE0200876A 2002-03-22 2002-03-22 Nässpray mot öroninflammationer SE0200876L (sv)

Priority Applications (8)

Application Number Priority Date Filing Date Title
SE0200876A SE0200876L (sv) 2002-03-22 2002-03-22 Nässpray mot öroninflammationer
DE60310212T DE60310212T2 (de) 2002-03-22 2003-03-06 Verwendung eines wasserstoffperoxid-produzierenden Enzyms zur Behandlung von Otitis Media
ES03745048T ES2277641T3 (es) 2002-03-22 2003-03-06 Utilizacion de una enzima productora de peroxido de hidrogeno para el tratamiento de otitis media.
AU2003215987A AU2003215987A1 (en) 2002-03-22 2003-03-06 Use of hydrogen peroxide producing enzyme for treatment of otitis media
EP03745048A EP1490096B1 (en) 2002-03-22 2003-03-06 Use of hydrogen peroxide producing enzyme for treatment of otitis media
AT03745048T ATE347370T1 (de) 2002-03-22 2003-03-06 Verwendung eines wasserstoffperoxid produzierenden enzyms zur behandlung von otitis media
US10/508,590 US20050238635A1 (en) 2002-03-22 2003-03-06 Use of hyrogen peroxide producting enzyme for treatment of otitis media
PCT/SE2003/000384 WO2003080109A1 (en) 2002-03-22 2003-03-06 Use of hydrogen peroxide producing enzyme for treatment of otitis media

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
SE0200876A SE0200876L (sv) 2002-03-22 2002-03-22 Nässpray mot öroninflammationer

Publications (2)

Publication Number Publication Date
SE0200876D0 SE0200876D0 (sv) 2002-03-22
SE0200876L true SE0200876L (sv) 2003-09-23

Family

ID=20287356

Family Applications (1)

Application Number Title Priority Date Filing Date
SE0200876A SE0200876L (sv) 2002-03-22 2002-03-22 Nässpray mot öroninflammationer

Country Status (8)

Country Link
US (1) US20050238635A1 (sv)
EP (1) EP1490096B1 (sv)
AT (1) ATE347370T1 (sv)
AU (1) AU2003215987A1 (sv)
DE (1) DE60310212T2 (sv)
ES (1) ES2277641T3 (sv)
SE (1) SE0200876L (sv)
WO (1) WO2003080109A1 (sv)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB0603975D0 (en) * 2006-03-01 2006-04-05 Etren Methods and agents for reducing oxidative stress
WO2009116944A1 (en) * 2008-03-20 2009-09-24 Krister Tano Use of a substance for manufacturing of a medicament for treatment of common cold
JP6825913B2 (ja) 2014-04-30 2021-02-03 マトケ・ホールディングス・リミテッド 抗菌組成物
GB201716986D0 (en) 2017-10-16 2017-11-29 Matoke Holdings Ltd Antimicrobial compositions

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SE8702831L (sv) * 1987-07-10 1989-01-11 Ewos Ab Microbicid komposition
GB9002422D0 (en) * 1990-02-03 1990-04-04 Boots Co Plc Anti-microbial compositions
US5389369A (en) * 1991-02-21 1995-02-14 Exoxemis, Inc. Halo peroxidase containing compositions for killing yeast and sporular microorganisms
AU663869B2 (en) * 1991-02-21 1995-10-26 Exoxemis, Inc. Methods and compositions for the treatment of infection and control of flora
SE506529C2 (sv) * 1996-01-23 1997-12-22 Semper Ab Användning av ett laktoperoxidassystem för framställning av ett läkemedel mot Helicobacter pylori
CO4910145A1 (es) * 1996-10-01 2000-04-24 Smithkline Beecham Corp Uso
GB9708641D0 (en) * 1997-04-29 1997-06-18 Knoll Ag Enzyme concentrate
DE29723959U1 (de) * 1997-07-22 1999-07-22 Zellner, Gerhard, Dr., 83435 Bad Reichenhall Nasenspray-Flüssigkeit
US6214339B1 (en) * 2000-01-12 2001-04-10 Michael A. Pellico Di-enzymatic treatment of outer ear infection in dogs and cats

Also Published As

Publication number Publication date
ES2277641T3 (es) 2007-07-16
DE60310212D1 (de) 2007-01-18
US20050238635A1 (en) 2005-10-27
EP1490096A1 (en) 2004-12-29
SE0200876D0 (sv) 2002-03-22
WO2003080109A1 (en) 2003-10-02
ATE347370T1 (de) 2006-12-15
EP1490096B1 (en) 2006-12-06
AU2003215987A1 (en) 2003-10-08
DE60310212T2 (de) 2007-10-11

Similar Documents

Publication Publication Date Title
AU2003239557A1 (en) Catheter balloon with ultrasonic microscalpel blades
DK1411932T3 (da) Kombinationsterapi med substituerede oxazolidinoner
MY144292A (en) Method of reducing oral tissue inflammation using magnolia extract
MXPA05008406A (es) Compuestos de amida tri(ciclo)-sustituida.
MX2009005783A (es) Uso de enzimas hidroliticas y oxidativas para disolver bio-peliculas en los oidos.
WO2002069945A3 (de) Neue arzneimittelkompositionen auf der basis von anticholinergika und pde-iv-inhibitoren
WO2005097119A3 (en) Pten inhibitors
PL362803A1 (en) Novel method and compositions for local treatment of meniere's disease, tinnitus and/or hearing loss
AU2001236886A1 (en) Use of relaxin to treat diseases related to vasoconstriction
TR200200260T2 (tr) N-desmetilzopiklonlarının üretim ve kullanım yöntemleri
WO2003100574A3 (en) Dental appliances and systems and methods for distributing dental appliances
AU2002234806A1 (en) Modulation of smr1-nep interactions in cns disorders giving rise to mental disorders
WO2005094836A3 (en) Use of loteprednol etabonate for the treatment of dry eye
AU2002317501A1 (en) Antiobestic and/or antidiabetic agent containing cyanidin 3-glucoside as active ingredient
WO2001089536A3 (en) Apoptotic entities for use in treatment of t-cell-mediated and inflammatory disorders
NZ507203A (en) Use of dexmedetomidine for ICU sedation
SE0200876L (sv) Nässpray mot öroninflammationer
AU2002332488A1 (en) R-bambuterol, its preparation and therapeutic uses
AR040657A1 (es) Tirita para refrescar el aliento mejorada por enzimas
WO2004060281A3 (en) 2-aryl thiazole derivatives as kcnq modulators
WO2006101954A3 (en) Interstitial cystitis treatment
EP1782824A3 (de) Pharmazeutische Zusammensetzungen, die Diaminooxidase enthalten
WO2007009895A3 (en) USE OF FACTOR VIIa OR FACTOR VIIa EQUIVALENTS FOR PREVENTING OR ATTENUATING HAEMORRHAGE GROWTH, AND/OR OEDEMA GENERATION FOLLOWING INTRACEREBRAL HAEMORRHAGE (ICH) IN PATIENTS TREATED WITH ANTIPLATELET THERAPY
UA97961C2 (ru) Способ лечения и/или улучшения диссеминированного внутрисосудистого свертывания крови
EP1495755B8 (fr) Utilisation de la citrulline dans la fabrication d'un médicament pour le traitement de l'insuffisance intestinale liée au vieillissement ou à une irradiation

Legal Events

Date Code Title Description
NAV Patent application has lapsed